AKRO
Price
$39.99
Change
-$1.96 (-4.67%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
3.34B
47 days until earnings call
SLS
Price
$1.10
Change
+$0.01 (+0.92%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
99.02M
35 days until earnings call
Ad is loading...

AKRO vs SLS

Header iconAKRO vs SLS Comparison
Open Charts AKRO vs SLSBanner chart's image
Akero Therapeutics
Price$39.99
Change-$1.96 (-4.67%)
Volume$27.91K
Capitalization3.34B
SELLAS Life Sciences Group
Price$1.10
Change+$0.01 (+0.92%)
Volume$674
Capitalization99.02M
AKRO vs SLS Comparison Chart
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKRO vs. SLS commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a Hold and SLS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (AKRO: $41.95 vs. SLS: $1.09)
Brand notoriety: AKRO and SLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 114% vs. SLS: 33%
Market capitalization -- AKRO: $3.34B vs. SLS: $99.02M
AKRO [@Biotechnology] is valued at $3.34B. SLS’s [@Biotechnology] market capitalization is $99.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whileSLS’s FA Score has 0 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • SLS’s FA Score: 0 green, 5 red.
According to our system of comparison, AKRO is a better buy in the long-term than SLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 4 TA indicator(s) are bullish while SLS’s TA Score has 4 bullish TA indicator(s).

  • AKRO’s TA Score: 4 bullish, 5 bearish.
  • SLS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AKRO is a better buy in the short-term than SLS.

Price Growth

AKRO (@Biotechnology) experienced а -3.10% price change this week, while SLS (@Biotechnology) price change was -7.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

AKRO is expected to report earnings on May 20, 2025.

SLS is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($3.34B) has a higher market cap than SLS($99M). AKRO YTD gains are higher at: 50.791 vs. SLS (4.808). SLS has higher annual earnings (EBITDA): -32.77M vs. AKRO (-247.37M). AKRO has more cash in the bank: 743M vs. SLS (21M). SLS has less debt than AKRO: SLS (576K) vs AKRO (36.5M). AKRO (0) and SLS (0) have equivalent revenues.
AKROSLSAKRO / SLS
Capitalization3.34B99M3,374%
EBITDA-247.37M-32.77M755%
Gain YTD50.7914.8081,056%
P/E RatioN/AN/A-
Revenue00-
Total Cash743M21M3,538%
Total Debt36.5M576K6,337%
FUNDAMENTALS RATINGS
SLS: Fundamental Ratings
SLS
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKROSLS
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 23 days ago
83%
Bullish Trend 30 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPYYY7.930.18
+2.32%
Centrica Plc
RNECY6.800.14
+2.10%
Renesas Electronics Corp
KUYAF0.22N/A
+1.99%
Kuya Silver Corp.
VWAGY10.410.14
+1.36%
Volkswagen AG
SYAXF0.01N/A
N/A
Sayona Mining Ltd.